A safe and minimally invasive implanted stimulation device is getting mostly positive reviews from neurosurgeons, with some experts saying it represents a "paradigm shift" in the treatment of ...
Groundbreaking neurostimulation technology offers hope and healing for difficult-to-manage pain. Chronic low back pain, a formidable foe causing disability and soaring healthcare costs, now faces a ...
The Food and Drug Administration (FDA) has approved ReActiv8® (Mainstay Medical), an implantable neurostimulation system, for the treatment of intractable chronic low back pain. Specifically, the ...
DUBLIN--(BUSINESS WIRE)--Mainstay Medical today announced that the United States Centers for Disease Control and Prevention (CDC) has designated an International Classification of Diseases, Tenth ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results